MedPath

Lipomed

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (50.0%)
Phase 3
1 (50.0%)

Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients

Phase 3
Completed
Conditions
Hemochromatosis
Interventions
First Posted Date
2006-07-11
Last Posted Date
2012-11-19
Lead Sponsor
Lipomed
Target Recruit Count
95
Registration Number
NCT00350662
Locations
🇪🇬

Pediatric Hospital, Cairo University, Cairo, Egypt

🇹🇷

EGE University Medical School, Bornova, Izmir, Izmir, Turkey

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

Phase 2
Completed
Conditions
Hemochromatosis
Interventions
First Posted Date
2006-07-07
Last Posted Date
2011-12-12
Lead Sponsor
Lipomed
Target Recruit Count
24
Registration Number
NCT00349453
Locations
🇨🇭

Cantonal Hospital, Children's Clinic, Aarau, Aargau, Switzerland

🇨🇭

Cantonal Hospital, Aarau, Aargau, Switzerland

🇨🇭

Cantonal Hospital Graubünden, Chur, Graubünden, Switzerland

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.